177 related articles for article (PubMed ID: 25690022)
1. Nocturia in patients with benign prostatic hyperplasia: evaluating the significance of ageing, co-morbid illnesses, lifestyle and medical therapy in treatment outcome in real life practice.
Singam P; Hong GE; Ho C; Hee TG; Jasman H; Inn FX; Bahadzor B; Tamil A; Zainuddin Z
Aging Male; 2015 Jun; 18(2):112-7. PubMed ID: 25690022
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant?
Smith AL; Wein AJ
BJU Int; 2011 May; 107(10):1550-4. PubMed ID: 21518417
[TBL] [Abstract][Full Text] [Related]
3. Comparison of add-on medications for persistent storage symptoms after α-blocker treatment in BPH patients - a network meta-analysis.
Su YT; Chen HL; Teoh JY; Chan VW; Wu WJ; Lee HY
BMC Urol; 2023 Oct; 23(1):154. PubMed ID: 37789333
[TBL] [Abstract][Full Text] [Related]
4. Re: Nocturia in Patients with Benign Prostatic Hyperplasia: Evaluating the Significance of Ageing, Co-Morbid Illnesses, Lifestyle and Medical Therapy in Treatment Outcome in Real Life Practice.
Kaplan SA
J Urol; 2016 Oct; 196(4):1219-20. PubMed ID: 27628818
[No Abstract] [Full Text] [Related]
5. Current pharmacotherapy of nocturia.
Smith A; Wein A
Expert Opin Pharmacother; 2013 May; 14(7):885-94. PubMed ID: 23556416
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
Kim JC; Cho KJ; Lee JG; Seo JT; Kim DY; Oh SJ; Lee KS; Choo MS; Lee JZ
J Urol; 2017 Feb; 197(2):459-464. PubMed ID: 27622611
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin add-on therapy for refractory nocturia in men receiving α-blockers for lower urinary tract symptoms.
Bae WJ; Bae JH; Kim SW; Chung BH; Kim JH; Kim CS; Lee HM; Lee KS; Yoo TK; Kim SI; Byun SS; Lee JY
J Urol; 2013 Jul; 190(1):180-6. PubMed ID: 23357213
[TBL] [Abstract][Full Text] [Related]
8. Comparison of nocturia response to desmopressin treatment in elderly men with and without nocturnal polyuria in real-life practice.
Chen SL; Huang YH; Hung TW; Ou YC
Int J Clin Pract; 2016 May; 70(5):372-9. PubMed ID: 27039892
[TBL] [Abstract][Full Text] [Related]
9. [Nocturia in men with benign prostatic hyperplasia].
Oelke M; Fangmeyer B; Zinke J; Witt JH
Aktuelle Urol; 2018 Aug; 49(4):319-327. PubMed ID: 30086589
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
Weiss JP; Herschorn S; Albei CD; van der Meulen EA
J Urol; 2013 Sep; 190(3):965-72. PubMed ID: 23454402
[TBL] [Abstract][Full Text] [Related]
11. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
Morlock R; Goodwin B; Gomez Rey G; Eaddy M
Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
[TBL] [Abstract][Full Text] [Related]
12. The evaluation and management of persistent nocturia.
Raskolnikov D; Friedman FM; Etwaru DJ; Weiss JP
Curr Urol Rep; 2014 Sep; 15(9):439. PubMed ID: 25007892
[TBL] [Abstract][Full Text] [Related]
13. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
14. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Silva J; Silva CM; Cruz F
Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
[TBL] [Abstract][Full Text] [Related]
15. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia.
Johnson TM; Burrows PK; Kusek JW; Nyberg LM; Tenover JL; Lepor H; Roehrborn CG;
J Urol; 2007 Nov; 178(5):2045-50; discussion 2050-1. PubMed ID: 17869295
[TBL] [Abstract][Full Text] [Related]
16. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for nocturia in the elderly patient.
Asplund R
Drugs Aging; 2007; 24(4):325-43. PubMed ID: 17432926
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
[TBL] [Abstract][Full Text] [Related]
19. Alfuzosin 10 mg once daily for treating benign prostatic hyperplasia: a 3-year experience in real-life practice.
Vallancien G; Emberton M; Alcaraz A; Matzkin H; van Moorselaar RJ; Hartung R; Harving N; Elhilali M;
BJU Int; 2008 Apr; 101(7):847-52. PubMed ID: 18321317
[TBL] [Abstract][Full Text] [Related]
20. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial.
Johnson TM; Jones K; Williford WO; Kutner MH; Issa MM; Lepor H
J Urol; 2003 Jul; 170(1):145-8. PubMed ID: 12796667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
